In 1996, the last time BIO held its international convention in Philadelphia, about 3,700 people attended. A decade later, BIO expects at least 18,000 convention-goers. ...
Milwaukee, Wis. - Limited partners, portfolio company executives, and guests of Mason Wells met in Milwaukee to hear a speech from Mark Hessen, president of the National Venture Capital Association, and listen to updates from six firms that Mason Wells invests in. ...
Though the number of drug blockbusters is on the rise, this situation is still limited mostly to Big Pharma and a few select other companies....
The global pharmaceutical market failed to reach double-digit growth in 2004 for the first time in about nine years. Key reasons for this focused on concerns over drug safety, pricing and competition from generic drugs as major products had their patents expire....
A drive to unite the research efforts of southeast Wisconsin received a boost late last week with an approved proposal for $2.5 million in research capital....
Madison, Wis. — The next alternative fuel source for Wisconsin may be where consumers least expect it – in the basement of a restaurant....
Madison, Wis. – Recent developments in Washington and Korea could have a lasting impact on Wisconsin's stem cell community, putting more roadblocks in scientists' search for funding....
Chippewa Valley Technical College has teamed up with UW-Eau Claire, UW-Stout and several other tech colleges to create the first Nanoscience Technology degree program in the state....
EraGen Biosciences in Madison landed an exclusive worldwide distribution agreement for its new cystic fibrosis assay, MultiCode PLx, to the Diagnostics Division of Bayer HealthCare LLC. ...
What's in a biotech village? And why doesn't it exist in Chicago and the Midwest? It does, but it's spread all over for the moment, argues Michael Rosen....